trending Market Intelligence /marketintelligence/en/news-insights/trending/xukchqjfk5sqwkt_uifila2 content esgSubNav
In This List

Kura Oncology closes $77.1M stock offering

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes

Blog

Investment Banking Essentials Newsletter April Edition - 2022


Kura Oncology closes $77.1M stock offering

Kura Oncology Inc. closed its public offering to raise about $77.1 million in gross proceeds.

The San Diego-based biopharmaceutical company issued 4.6 million common shares at $16.75 apiece, which included 600,000 shares bought by the underwriters after they exercised their option in full.

Leerink Partners acted as sole book-running manager for the offering.